NOVEL GOLD-BASED NAN... 申请号：JP2018147599 专利类型：发明申请 公开（公告）日：2018-08-06
状态：寻求转化 转让价格：面议
PROBLEM TO BE SOLVED : To provide pharmaceutically acceptable suspensions and nanocrystal shape distributions, which include novel gold nanocrystals with surfaces substantially free from organic imp...
NOVEL FUNCTIONALIZED... 申请号：WOEP18070522 专利类型：其他 公开（公告）日：
状态：寻求转化 转让价格：面议
There is provided compounds of formula (I), or pharmaceutically-acceptable salts thereof, wherein R1 to R4 and X1 to X5 have meanings provided in the description, which compounds are useful in the ...
NOVEL FUNCTIONALIZED... 申请号：CA3069065 专利类型：发明申请 公开（公告）日：2018-07-27
状态：寻求转化 转让价格：面议
There is provided compounds of formula (I), or pharmaceutically-acceptable salts thereof, wherein R1 to R4 and X1 to X5 have meanings provided in the description, which compounds are useful in the ...
NOVEL FUNCTIONALIZED... 申请号：WOEP18070522 专利类型：发明申请 公开（公告）日：2018-07-27
状态：寻求转化 转让价格：面议
There is provided compounds of formula (I), or pharmaceutically-acceptable salts thereof, wherein R1 to R4 and X1 to X5 have meanings provided in the description, which compounds are useful in the ...
NOVEL FAP INHIBITORS 申请号：EP13701410 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention relates to novel inhibitors having high selectivity and specificity for FAP (fibroblast activation protein). Said inhibitors are useful as a human and/or veterinary medicine, in...
NOVEL ENGINEERED T C... 申请号：WOEP18080176 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention pertains to antigen recognizing constructs against COL6A3 antigens. The invention in particular provides novel engineered T cell receptor (TCR) based molecules which are selectiv...
NOVEL EGFR BINDING P... 申请号：EP16702945 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention relates to new EGFR binding molecules based on ubiquitin muteins (Affilin?, preferably Affilin molecules having a characteristic three amino acid residue motif. The invention fu...
NOVEL DIMERS OF CYTI... 申请号：RU2017120032 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
FIELD : chemistry.SUBSTANCE : present invention relates to a dimer of a cytidine derivative of formula (I), use thereof for producing an antitumour agent, pharmaceutical compositions based thereon...
NOVEL CRYSTALLINE FO... 申请号：US16578676 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
A solid form of 1-(4-{[6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone, or pharmaceutically acceptable salts thereof, are useful as BTK inhibitors.
NOVEL CRYSTALLINE FO... 申请号：US16578676 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
A solid form of 1-(4-{[6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone, or pharmaceutically acceptable salts thereof, are useful as BTK inhibitors.
